NCT00410657View on ClinicalTrials.gov

Alemtuzumab and Glucocorticoids in Treating Newly Diagnosed Acute Graft-Versus-Host Disease in Patients Who Have Undergone a Donor Stem Cell Transplant

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

July 31, 2006

Primary Completion Date

November 30, 2006

Conditions

Breast CancerChronic Myeloproliferative DisordersGestational Trophoblastic TumorGraft Versus Host DiseaseLeukemiaLymphomaMultiple Myeloma and Plasma Cell NeoplasmMyelodysplastic SyndromesMyelodysplastic/Myeloproliferative DiseasesNeuroblastomaOvarian CancerTesticular Germ Cell Tumor

Interventions

BIOLOGICAL

alemtuzumab

DRUG

methylprednisolone

DRUG

prednisone

OTHER

flow cytometry

OTHER

immunologic technique

OTHER

pharmacological study

Trial Locations (1)

98109-1024

Fred Hutchinson Cancer Research Center, Seattle

All Listed Sponsors

collaborator

National Cancer Institute (NCI)

NIH

lead

Fred Hutchinson Cancer Center

OTHER

NCT00410657 - Alemtuzumab and Glucocorticoids in Treating Newly Diagnosed Acute Graft-Versus-Host Disease in Patients Who Have Undergone a Donor Stem Cell Transplant | Biotech Hunter | Biotech Hunter